Toyomasa Katagiri
Director/Board Member at Cancer Precision Medicine KK
Toyomasa Katagiri active positions
| Companies | Position | Start | End |
|---|---|---|---|
| The University of Tokushima | Corporate Officer/Principal | 30/04/2008 | - |
Immunas Pharma, Inc.
 Immunas Pharma, Inc. Pharmaceuticals: MajorHealth Technology Immunas Pharma, Inc. develops anti-cancer antibody medicines. The company is based in Kawasaki, Japan. Immunas Pharma was acquired by OncoTherapy Science, Inc. on September 30, 2007 for $0.43 million. | Director/Board Member | 30/11/2014 | - |
| Cancer Precision Medicine KK | Director/Board Member | 30/04/2018 | - |
Career history of Toyomasa Katagiri
Former positions of Toyomasa Katagiri
| Companies | Position | Start | End |
|---|---|---|---|
| ONCOTHERAPY SCIENCE, INC. | Director/Board Member | 31/05/2010 | 30/03/2023 |
Statistics
International
| Japan | 5 |
Operational
| Director/Board Member | 3 |
| Corporate Officer/Principal | 1 |
Sectoral
| Health Technology | 3 |
| Consumer Services | 2 |
Positions held
Active
Inactive
Listed companies
Private companies
Linked companies
| Listed companies | 1 |
|---|---|
| ONCOTHERAPY SCIENCE, INC. | Health Technology |
| Private companies | 2 |
|---|---|
Immunas Pharma, Inc.
Immunas Pharma, Inc. Pharmaceuticals: MajorHealth Technology Immunas Pharma, Inc. develops anti-cancer antibody medicines. The company is based in Kawasaki, Japan. Immunas Pharma was acquired by OncoTherapy Science, Inc. on September 30, 2007 for $0.43 million. | Health Technology |
| Cancer Precision Medicine KK |
- Stock Market
- Insiders
- Toyomasa Katagiri
- Experience
